Penile Enhancement Functional Outcomes: What Clinical Evidence Confirms

Introduction: The Functional Question Every Informed Patient Is Actually Asking

Men researching penile enhancement are not primarily asking “how much size will I gain?” They are asking something far more fundamental: “Will this procedure compromise anything that already works?”

This distinction matters. Men who have conducted preliminary research need clinical confirmation, not marketing reassurance. They require peer-reviewed evidence addressing urinary function, erectile mechanics, sensation, and ejaculation—including the underreported finding that properly performed enhancement can actually improve ejaculatory latency.

A critical nuance runs throughout the clinical literature that most competing content ignores: evidence-based, properly performed procedures demonstrate fundamentally different outcomes than unregulated or improperly performed ones. The risk profile is not inherent to enhancement as a category—it is a function of technique, provider qualification, and material selection.

The baseline reality is this: the vast majority of men who seek penile enhancement have a normally sized and normally functioning penis. According to research published in European Urology, these procedures are cosmetic in intent, not corrective of functional deficits. This framing is essential for understanding the clinical evidence that follows.

Stoller Medical Group, operating as Penis Enlargement New York City, is a practice whose clinical approach is grounded in this evidence-forward framework. With over 15,000 procedures performed under the direction of Dr. Roy B. Stoller, the practice’s volume exceeds most published clinical trial cohorts—providing real-world validation of the safety principles outlined in peer-reviewed literature.

Anatomy First: Why Procedure Plane Determines Functional Outcome

Understanding functional outcomes requires understanding penile anatomy—specifically the layered fascial architecture that makes safe enhancement possible.

The key anatomical layers from skin inward include: skin → Dartos fascia (superficial) → Buck’s fascia (deep) → tunica albuginea → corpora cavernosa and corpus spongiosum. Each layer serves distinct functions, and their relationships determine procedural safety.

Buck’s fascia plays a critical role. It encases the corpora cavernosa, corpus spongiosum, and the dorsal neurovascular bundle. Its integrity is essential for normal erectile function. This fascial layer acts as the anatomical boundary between safe procedural territory and the structures that govern sexual and urinary function.

Properly performed hyaluronic acid (HA) filler enhancement is placed in the sub-Dartos plane, above Buck’s fascia—a surgical plane that is anatomically remote from every structure governing erection, sensation, urination, and ejaculation.

A December 2025 study published in PRS Global Open used ultrasound imaging to visually confirm HA filler placement between the Dartos and Buck’s fascia, demonstrating clear anatomical safety margins. This imaging evidence validates what anatomical theory predicts: correct technique places enhancement material in a compartment separated from functional structures by fascial barriers.

Four critical structures must be avoided during enhancement procedures—and are avoided in properly performed procedures: the dorsal neurovascular bundle, deep dorsal vein, dorsal arteries, and urethra.

The Neurovascular Bundle: Sensation and Erectile Mechanics Preserved

The dorsal neurovascular bundle consists of paired dorsal nerves, dorsal arteries, and the deep dorsal vein running beneath Buck’s fascia along the dorsal midline of the penis. These structures govern both penile sensation (via the dorsal nerves) and the arterial inflow that drives erection—making their preservation non-negotiable.

HA filler injected above Buck’s fascia never contacts the neurovascular bundle. The fascia itself acts as a physical barrier, creating an anatomical separation that makes nerve damage structurally impossible when correct technique is employed.

For surgical approaches such as the Penuma or Himplant, modern techniques specifically engineer neurovascular bundle mobilization—not transection—to preserve dorsal nerves and arteries. A January 2026 paper in Current Urology confirmed that neurovascular-preserving surgical approaches are the standard for Penuma implantation, “reducing operative time and morbidity.”

The practical takeaway: when performed in the correct anatomical plane by a qualified physician, enhancement procedures are structurally incapable of damaging the nerves and vessels that govern sensation and erection.

Urinary Function: Why the Urethra Is Never in the Procedural Field

Urinary function concerns represent a top patient worry that most competing content ignores entirely.

The urethra runs through the corpus spongiosum, which lies ventral and deep—well beneath Buck’s fascia and entirely outside the sub-Dartos procedural plane. The urinary sphincter mechanism (internal and external sphincters) is located at the bladder neck and pelvic floor, anatomically distant from the penile shaft where enhancement occurs.

The December 2025 PRS Global Open study explicitly listed the urethra as a “critical structure that must be avoided during filler placement”—and confirmed that correct technique does avoid it. In multi-institutional Penuma data covering 228 patients, no urinary dysfunction was reported as a procedure-specific outcome.

The evidence is unambiguous: properly performed penile girth enhancement—whether HA filler or implant—does not enter the anatomical territory of the urethra, bladder neck, or urinary sphincter.

Clinical Evidence on Erectile Function: What the Trials Actually Show

The anatomical safety argument is validated by real patient outcomes across multiple clinical trials.

The landmark Penuma study by Elist and colleagues, published in the Journal of Sexual Medicine, followed over 400 patients and reported that “no patients reported any changes in sexual function, erections, or ejaculation,” while 81% reported “high” or “very high” long-term satisfaction.

Multi-institutional Penuma data published in Therapeutic Advances in Urology demonstrated significantly increased flaccid length and girth, with complications described as “mainly cosmetic”—not functional. A PRISMA-compliant systematic review of 46 studies published in MDPI Medicine examined autologous fat and ADM grafting series, reporting “no erectile dysfunction was reported, and satisfaction of patients ranged between 90 and 100%.”

A 2023 meta-analysis of four randomized controlled trials covering 283 subjects found no serious adverse events and no reports of erectile or urinary dysfunction among HA and PLA filler recipients.

Penile traction therapy studies using validated IIEF-5/SHIM scores showed average erectile function score improvements of 4–8 points, confirming that non-surgical enhancement approaches can actually improve—not harm—erectile function. These are gold-standard clinical instruments for erectile function assessment, not subjective patient impressions.

The Underreported Finding: Enhancement Can Improve Ejaculatory Latency

A prospective, randomized, multicenter trial by Ahn and colleagues published in World Journal of Men’s Health studied 64 patients receiving HA and PLA fillers. The results showed significant girth gains (22.74 mm in the HA group), improved ejaculatory latency time (IELT), and improved sexual satisfaction—with no reports of erectile dysfunction or urinary interference.

A 2023 narrative review confirmed that HA glans injections can treat premature ejaculation, demonstrating that HA-based enhancement has documented functional therapeutic applications beyond aesthetics.

The proposed mechanism: increased girth may reduce penile sensitivity at the glans through a mild desensitization effect mediated by filler volume, extending intravaginal ejaculatory latency time without impairing the ejaculatory reflex itself.

Improved IELT represents a clinical benefit for men with premature ejaculation concerns. For a subset of patients, properly performed HA girth enhancement may deliver a functional benefit in addition to the aesthetic outcome.

Sensation Preservation: What the Evidence Confirms

Sensation preservation represents a distinct functional domain separate from erectile mechanics and ejaculation.

The anatomical basis is straightforward: dorsal penile nerves travel beneath Buck’s fascia. HA filler placed above Buck’s fascia does not contact these nerve fibers.

A 500-patient retrospective study covered in Urology Times reported that the lead investigator confirmed “no reports of erectile dysfunction or penile sensation loss” in the HA filler cohort. The 2023 meta-analysis found no serious adverse events, including no sensation loss, across four RCTs and 283 subjects.

For surgical approaches, multi-institutional Penuma data confirmed that the implant’s subcutaneous placement above the corpora cavernosa is specifically designed to avoid the neurovascular bundle.

Mild, transient glans numbness has been reported in penile traction therapy studies as a minor, self-resolving adverse effect—not permanent sensation loss—and is not associated with HA filler procedures.

The sub-Dartos/above-Buck’s-fascia plane is not merely a technical preference. It is the anatomically mandated safe zone that makes sensation preservation a structural guarantee of correct technique.

The Indirect Functional Benefit: Resolving Penile Size Anxiety

The psychogenic dimension of functional outcomes represents a compelling, evidence-backed consideration that most competing content overlooks entirely.

According to EAU Guidelines, subjective penile size perception negatively impacts sexual function and quality of life in approximately 10% of men. The paradox is notable: up to 45% of men report size dissatisfaction at some point, yet 84% of female partners report satisfaction with their partner’s size. The functional impairment is primarily psychological, not anatomical.

A 2023 prospective study published in Aesthetic Surgery Journal found that approximately 50% of men reported increased self-confidence and sexual pleasure following HA girth augmentation, with no reports of functional deterioration.

Penile size anxiety can manifest as psychogenic erectile dysfunction—performance anxiety disrupts the parasympathetic cascade required for erection. Resolving the anxiety removes the psychological barrier to function. Enhancement can therefore restore sexual function in men whose dysfunction was driven by size-related psychological distress rather than organic pathology. This psychogenic dimension is explored further in our analysis of penis enhancement partner satisfaction outcomes.

When Functional Complications Do Occur: Understanding the Real Risk Profile

Functional complications—erectile dysfunction, sensation loss, urinary dysfunction—are associated almost exclusively with improperly performed procedures, unregulated substances, or non-medical practitioners. They are not associated with evidence-based, physician-performed enhancement.

A 2025 narrative review in the International Journal of Impotence Research distinguishes sharply between approved HA filler outcomes (favorable safety profile) and unapproved foreign body injections—liquid silicone, paraffin, mineral oil—which are associated with severe complications including dysfunction.

The University of South Florida’s 2025 review in Translational Andrology and Urology confirmed that complication profiles of HA injections are manageable and mainly cosmetic when performed correctly. Functional complications arise from technique errors or wrong-plane injection.

The risk of functional harm is not inherent to enhancement—it is a function of provider qualification, material choice, and technique.

The Stoller Medical Group Approach: Clinical Protocol Aligned With the Evidence

The practice’s HA filler placement in the sub-Dartos plane, above Buck’s fascia, directly mirrors the evidence-based technique confirmed in published ultrasound studies and randomized controlled trials.

Dr. Roy B. Stoller brings 25 years of experience in aesthetic and restorative medicine, with five years dedicated specifically to non-surgical male enhancement and over 15,000 procedures performed—volume that exceeds most published clinical trial cohorts.

The staged treatment protocol serves as a functional safety feature. Incremental sessions reduce the risk of over-injection, asymmetry, and wrong-plane placement—the primary technical causes of complications.

The practice’s decision not to offer surgical penile lengthening reflects a safety-first approach that aligns with EAU and SMSNA guidance on risk-benefit assessment. The 7–10 day return to sexual activity timeline is consistent with clinical trial recovery data.

Summary of Clinical Evidence: Functional Outcomes at a Glance

Urinary function: No procedure-specific urinary dysfunction reported in any major HA filler or Penuma trial; the urethra is anatomically outside the procedural plane.

Erectile function: No erectile dysfunction reported in the Penuma landmark study (400+ patients), HA/PLA RCT meta-analysis (283 subjects), or 500-patient retrospective cohort; traction studies show IIEF score improvements of 4–8 points.

Sensation: No permanent sensation loss reported in any major evidence-based enhancement trial; dorsal nerves are protected by the Buck’s fascia barrier in filler procedures.

Ejaculation: No ejaculatory dysfunction reported; clinical trials confirm improved ejaculatory latency time as a positive functional outcome.

Psychological function: Approximately 50% of patients report increased self-confidence and sexual pleasure post-procedure.

Conclusion: Clinical Evidence Confirms Enhancement Is Functionally Additive, Not Subtractive

The anatomy-first analysis and peer-reviewed clinical trial data converge on a single conclusion: properly performed penile enhancement, placed in the correct sub-Dartos plane above Buck’s fascia, does not compromise urinary function, erectile mechanics, sensation, or ejaculation.

The evidence goes beyond “no harm.” Multiple trials document measurable functional benefits including improved ejaculatory latency and resolution of psychogenic erectile barriers.

Functional safety is not a property of enhancement as a category—it is a property of correct technique, qualified providers, and evidence-based materials. The provider choice is the functional safety decision.

Ready to Review the Evidence With a Clinical Expert? Schedule a Consultation

The logical next step for those who have reviewed the clinical evidence is applying it to specific anatomy and goals through a qualified consultation.

Stoller Medical Group offers free consultations with Dr. Stoller, whose 15,000+ procedure experience provides clinical credibility that exceeds most published trial cohorts. The practice operates across five locations—Manhattan, Long Island, Albany, Pennsylvania, and Minnesota—providing geographic convenience for prospective patients.

Discretion and confidentiality are consultation priorities.